United States · 
Who invested in BlossomHill Therapeutics?
BlossomHill Therapeutics's investors include OrbiMed, Janus Henderson Investors, Cormorant Asset Management and Vivo Capital.
United States · Series B startup
Who invested in BlossomHill Therapeutics
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 11 months ago
Funding summaryUpdated 26 Oct 2026
$84Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $84MDec 2025
- Investors
- 4
The rounds
- Dec 2025Series B$84M
Source recordedSEC filing: $84M sold, first sale Nov 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about BlossomHill Therapeutics
How much has BlossomHill Therapeutics raised?
BlossomHill Therapeutics has raised $84M across 1 round since 2025.
When did BlossomHill Therapeutics last raise?
BlossomHill Therapeutics's most recent round was a Series B of $84M in Dec 2025.
What was BlossomHill Therapeutics's biggest round?
Its most recent round, $84M in Dec 2025, is also its largest on record.
Who backed BlossomHill Therapeutics first?
BlossomHill Therapeutics's first round on record, in Dec 2025, was backed by OrbiMed, Janus Henderson Investors and Cormorant Asset Management and 1 others.
What stage is BlossomHill Therapeutics at?
BlossomHill Therapeutics's latest named round is a Series B, in Dec 2025.
Where is BlossomHill Therapeutics based?
BlossomHill Therapeutics is based in the United States.
Companies like BlossomHill Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.